RecruitingNCT06465745

ATLAS

ATLAS (AltaValve) Pivotal Trial

4C Medical Technologies, Inc.Multiple US sitesView on ClinicalTrials.gov

AI Description

This is a prospective, single arm, multicenter, clinical trial designed to evaluate the safety and performance of the AltaValve System for the treatment of mitral regurgitation in a targeted patient population.

Report inaccurate information

Who can join
adult, older adult
Participants
450
Expected completion
2031-09
Funded by
industry

Conditions studied

Mitral Incompetence, Mitral Insufficiency, Mitral Regurgitation, Mitral Valve Incompetence, Mitral Valve Regurgitation

What is being tested

  • DEVICE: AltaValve System.

What it measures

  • Composite of all-cause mortality or heart failure hospitalization., 12 months.

Centers Participating

These centers are participating in this study. Reach out to them directly to learn more.

Data Sources and Methodology

Registry entry updated 2026-08-03

Deciding whether to join a study is your choice, and you can ask a study team questions before you decide anything.

If you would rather we did it with you, call us on (656) 206-4686.